Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independent
Name
Chen_Persistence of.pdf
Size
1.88 MB
Format
Adobe PDF
Checksum (MD5)
684c17e7aeb0373a205667240ade23d7
Author(s)
Olurinde, Mobolaji O.
Drake, Adam
Bai, Ailin
Chen, Jianzhu
Shen, Chase
Date Issued
September 2011
Journal
Cellular and Molecular Immunology
Publisher
Nature Publishing Group
Citation
Olurinde, Mobolaji O et al. “Persistence of Tumor-infiltrating CD8 T Cells Is Tumor-dependent but Antigen-independent.” Cellular and Molecular Immunology 8.5 (2011): 415–423.
Version
Author's final manuscript
Abstract
How tumor-infiltrating lymphocytes (TILs) that are tumor-specific but functionally tolerant persist in the antigen-expressing tumor tissue is largely unknown. We have previously developed a modified TRansgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model where prostate cancer cells express the T-cell epitope SIYRYYGL (SIY) recognized by CD8 T cells expressing the 2C T-cell receptor (TCR) (referred to as TRP-SIY mice). In TRP-SIY mice, activated 2C T cells rapidly become tolerant following infiltration into the prostate tumor. In this study, we show that tolerant 2C T cells persist in the prostate tumor of TRP-SIY mice by proliferating slowly in a tumor-dependent, but antigen-, interleukin (IL)-7- and IL-15-independent manner. We also show that disappearance of 2C T cells from the lymphoid organs of TRP-SIY mice are due to antigen-induced T-cell contraction rather than altered trafficking or generalized T-cell depletion in the mice. Finally, we show that clonal T cells unreactive to SIY are equally capable of persisting in the prostate tumor. These findings suggest that while functional tolerance of TILs is induced by antigen, persistence of tolerant TILs in the tumor tissue is mediated by a novel mechanism: slow proliferation independent of antigen and homeostatic cytokines. These results also allow CD8 T-cell survival in the tumor environment to be compared with T-cell survival in chronic infection.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Biology
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike 3.0
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1038/cmi.2011.18
